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Introduction Medication adherence is very important for the effective treatment or control 
of various health problems, including chronic disease like diabetes mellitus 
(DM). However, medication non-adherence among diabetic patients on 
follow-up treatment is still a global health problem. This study aimed to 
identify factors associated with medication adherence and to determine 
methods on how it could be improved.
Methods A cross-sectional study was conducted on medication adherence among 
Malays, Iban and Melanau ethnic groups in Kota Samarahan and Sarikei, 
Sarawak using the Health Belief Model framework. Interviews with 
questionnaires, which were tested for its validity and reliability using the 
Cronbach’s Alpha, were conducted to collect data on the respondent’s socio-
demographic and economic characteristics, and health beliefs of 442 
respondents. Data was analyzed using SPSS version 17.0 for frequency 
distribution, measures of central tendencies, significance testing and logistic 
regression.
Results The medication adherence rates were low in terms of all the treatment 
indicators such as amount of medication (31.7%), frequency (38.9%), 
duration (26%), and follow-up treatment (24.2%). The respondent’s socio-
economic and economic characteristics have statistically significant 
association with medication adherence. The respondents adhered towards 
medication because they believed in its benefits. They also took their 
medication because they believed in the severity of DM and their 
susceptibility to its serious complications. The cues to action (medication 
taking) such as worrying about their socio-economic well-being, 
effectiveness of medication, and health campaign on diabetic control have 
influenced medication adherence. However, forgetfulness, distance of clinic, 
and costs of transport have caused medication non-adherence.
Conclusions The respondent’s health beliefs in the benefits of taking medication, 
perceived severity and susceptibility to DM and its serious complications 
have contributed towards medication adherence. Their concerns about the 
socio-economic well-being, effectiveness of medication, and health campaign 
on diabetic control were positive cues to medication taking behavior.
Therefore, modifying the respondent’s related health beliefs and reinforcing 
the positive cues to actions are the relevant intervention strategies that could 
be used in improving medication adherence among diabetic patients.
Keywords Diabetes mellitus - Health Belief Model - health beliefs - medication 
adherence - Sarawak. 
PUBLIC HEALTH RESEARCH
International Journal of Public Health Research Vol 3 No 1 2013, pp (236-240)
237
INTRODUCTION
Diabetes mellitus (DM) is a chronic metabolic 
disorder that cannot be treated, but can be 
controlled to prevent its complications1, 2, 3, 4.
Medication adherence is very important in the 
control of the disease5. However, medication non-
adherence is still a global health problem which is 
common among diabetic patients on follow-up 
treatment. The two main problems of non-
adherence with diabetic regimens were exercise 
(85%) and dietary recommendations (62%). The 
other problems include oral hyperglycemic 
medication, insulin injection and follow-up 
treatment 6, 7. The problem occurred due to long 
duration of treatment and lifestyles modification 8, 
9. There were several factors associated with 
medication adherence. These include 
characteristics of the disease10, 11, 12, 13, 14, patient 
characteristics, patient-doctor relationship and the 
complex health care system 14, 15. Medication non-
adherence can result in worsening of the disease 
and development of complications 16, 17. Besides, it 
may lead to treatment changes and failures18, 19 and 
increase in health care costs3, 20, 21 . Therefore, this 
study aims to identify factors associated with 
medication adherence and determine methods on 
how it should be improved.
METHODS
The cross-sectional study applied the Health Belief 
Model (HBM) framework to examine the 
relationship between diabetic patient’s health 
beliefs and medication adherence. A stratified 
random sampling method was used to select 442 
samples for the study. Data collection on the 
respondents’ socio-demographic and economic 
characteristics, medication adherence, and health 
beliefs were obtained by questionnaire interviews 
(the questionnaires were tested for its reliability 
and validity using the Cronbach’s Alpha). The 
collected data was analyzed using SPSS version 
17.0 for frequency distribution, measures of central 
tendencies, significance testing and logistic 
regression.
RESULTS
Most of the respondents (61.6%) were 51 years old 
and above. About 63.8% were females, and 
belonging to Malay ethnic group (63.1%). They 
were mostly married (98.4%). Only 40.3% of the 
respondents have no formal education. About 
91.1% of them were unemployed or housewives 
and 61.7% were having monthly income less than 
RM1000. The lowest adherence rate was for 
follow-up treatment (24.2%), and the highest 
(38.9%) for frequency in taking medication. There 
were statistically significant associations (p<0.05) 
between socio-demographic and economic factors 
such as age, race, education level, occupation, 
household income, distance of clinic, and transport 
costs with medication adherence. Health beliefs 
about the seriousness of DM (Table 1), benefits of 
treatment (Table 2), and self-efficacy in taking 
medication (Table 3) also have statistically 
significant associations (p<0.05) with medication 
adherence. The multiple logistic regression analysis 
has shown that health beliefs about the severity of 
DM, benefits of treatment, and self-efficacy in 
taking medication were the three main predictors of 
medication adherence (Table 4).
DISCUSSION
Most of the respondents who perceived that DM 
was a serious disease and that they were
susceptible to its complications were compliant 
towards medication. This finding was consistent 
with that of other study4 on a similar subject. There 
was statistically significant association (p<0.05) 
between these perceptions and medication 
adherence. This indicated that perceptions 
regarding the severity and susceptibility to DM 
were factors that can predict medication adherence 
among the respondents. Those who believed about 
the severity and susceptibility to the disease would 
be adherent with the prescribed medication4, 22.
The subject’s health beliefs about the 
benefits of taking treatment were also significantly 
associated (p<0.05) with medication taking 
behavior. This finding concurred with that of other 
study23 which revealed the significant association 
between belief about the benefits of taking 
medication and medication adherence. This implied 
that the positive beliefs about taking medication 
were predictors of medication adherence.
It was discovered that some respondents 
faced certain barriers in adhering with the diabetic 
treatment regimens, in terms of the frequency in 
taking medication as well as attending follow-up 
treatment. The respondent’s beliefs about these 
barriers have statistically significant association 
(p<0.05) with medication adherence. Other 
researchers 24, 25 have reported the same finding, 
which concluded that beliefs about barriers in 
taking medication would result in medication non-
adherence.
There were statistically significant 
associations (p<0.05) between health beliefs about 
self-efficacy in taking medication and medication 
taking behavior. This finding was similar to that 
reported by other researchers26, which showed that 
health beliefs of self-efficacy in taking medication 
have influenced the patients’ medication adherence.
CONCLUSIONS
The respondent’s health beliefs about the severity 
of DM and their susceptibility to the complications 
of the disease have positively contributed towards 
medication adherence. They would also take their 
medication, if they believed in its benefits. The 
subjects’ concerns about their socio-economic 
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well-being, beliefs in the effectiveness of 
medication, and health campaign on diabetic 
control were positive cues to medication taking 
behavior. Modifying the related health beliefs and 
reinforcing the positive cues to actions are the 
relevant intervention strategies that could be used 
in improving medication adherence of diabetic 
patients.
Table 1 Distribution of mean scores of health beliefs about perceived susceptibility and severity of DM and 
medication adherence
Mean scores of health beliefs on medication adherence
_______________________________________________________________________________________
Variables Problem in:
AmountFrequency Duration Follow-up
___________________________________________________________
Yes No Yes No Yes No Yes No
_______________________________________________________________________________________
Perceived susceptibility
and severity 13.4± 15.7± 2.8± 16.2± 14.1± 14.1± 14.1± 14.2±
(mean ± sd) 5.5 6.7 4.4 7.4 6.0 5.8 6.5 3.8
p value 0.001 0.001 0.972 0.912
p value reached from independent sample t test
Note: Yes = Have problem (Non-adherent) No = No problem (Adherent)
Table 2 Distribution of mean scores of beliefs about benefits of taking medication and medication adherence
Mean scores of health beliefs on medication adherence
_______________________________________________________________________________________
Variables Problem in:
AmountFrequency Duration Follow-up
___________________________________________________________
Yes No Yes No Yes No Yes No
_______________________________________________________________________________________
Benefits of taking
medication 14.9± 17.7± 14.1± 18.5± 15.7± 16.0± 15.8± 15.7± 
(mean ± sd) 4.3 4.4 3.8 4.3 4.7 4.0 5.0 2.8
p value 0.001 0.001 0.478 0.864
p value reached from independent sample t test
Note: Yes = Have problem (Non-adherent) No = No problem (Adherent)
Table 3 Distribution of mean scores on beliefs about self-efficacy in taking medication and medication 
adherence
Mean scores of health beliefs on medication adherence
_______________________________________________________________________________________
Variables Problem in:
AmountFrequency Duration Follow-up
___________________________________________________________
Yes No Yes No Yes No Yes No
_______________________________________________________________________________________
Self-efficacy in taking
medication 19.8± 19.3± 20.1± 18.8± 19.7± 19.4± 19.2± 21.0± 
(mean ± sd) 3.0 3.1 3.0 3.0 3.1 3.0 3.1 2.5
p value 0.119 0.001 0.409 0.001
p value reached from independent sample t test
Note: Yes = Have problem (Non-adherent) No = No problem (Adherent)
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Table 4 Factors affecting medication adherence: Multinomial logistic regression
0=Non-adherent (RC); 1= partially adherent; 2=completely adherent
Independent variables Partial adherence Complete adherence
β OR 
(95% CI)
β OR
(95% CI)
Previous condition of DM
Not serious -0.727*** 0.483
(0.312, 0.749)
-1.22** 0.295 
(0.13, 0.672)
Serious  (RC) - - - -
Health Belief Model
Perceived susceptibility and severity of 
DM
0.033 1.034
(0.984,1.086)
-0.008 0.992 
(0.902, 1.09)
Benefit of taking medication 0.173** 1.189 
(1.104, 1.282)
0.162* 1.176
(1.027, 1.346)
Barriers in taking medication -0.031 0.970 
(0.893, 1.053)
0.092 1.097 
(0.936, 1.284)
Self-efficacy of taking medication -0.077** 0.926 
(0.858, 0.999)
-0.041 0.960
(0.833, 1.106)
Intercept -0.452 -0.377
Model Chi square 92.486
df 12
n 442
RC     Reference Category
*p<0.05, **p<0.01, ***p<0.001
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